Related Experiment Video
Updated: Jun 5, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Light and intermittent tobacco smokers]
1Unité de Tabacologie, Service de Pneumologie, CHU La Milétrie, Pavillon René-Beauchant, BP 577, 86021 Poitiers Cedex, France. m.underner@chu-poitiers.fr
Revue Des Maladies Respiratoires
|December 18, 2010
Summary
Even light and intermittent tobacco smokers (LITS) face significant health risks, including cardiovascular disease and cancer. Public health campaigns must address LITS, as any smoking level is harmful.
Area of Science:
- Tobacco control research
- Public health
- Epidemiology
Context:
- Limited research exists on light and intermittent tobacco smokers (LITS) compared to moderate/heavy smokers.
- LITS are often younger, female, single, highly educated, and from minority groups.
- Existing terminology for LITS is inconsistent, lacking a precise definition.
Purpose:
- To highlight the health risks associated with light and intermittent tobacco smoking (LITS).
- To emphasize the need for targeted interventions for LITS.
- To underscore that all levels of smoking are detrimental.
Summary:
- LITS exhibit higher morbidity and mortality rates than expected, despite smoking fewer cigarettes.
- Light daily smoking increases risks of ischemic heart disease and lung cancer.
- Intermittent smoking is linked to elevated cardiovascular mortality, cough, and shortness of breath.
Impact:
- Medical advice and public health campaigns should specifically target LITS for cessation.
- Recognizing the risks of LITS is crucial for comprehensive tobacco control strategies.
- Any level of cigarette smoking poses health detriments, necessitating broader intervention efforts.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...